CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetic medicine company developing disruptive technologies and products based on its proprietary, non-animal recombinant human collagen ...

New York Tech and UC Irvine develop a 3D-printed human colon model to advance cancer drug testing and gastrointestinal ...

Researchers in Germany have created a groundbreaking 3D printer designed to print living tissue in the body through tiny ...

Swiss researchers recently have been developing 3D printed, biocompatible corneal implants that restore vision without donor ...

Organoids are three-dimensional, self-organizing structures derived from stem cells that faithfully mimic the complexity of ...

An update from Collplant Holdings ( ($CLGN) ) is now available. On October 16, 2025, CollPlant Biotechnologies announced the development of a ...

Saudi Arabia's 3D printing medical devices market is driven by the growing demand for personalized implants and prosthetics, ...

October is Breast Cancer Awareness Month and, according to the American Cancer Society, in this year alone more than 316,000 US women are projected to be diagnosed with an invasive ...

As an emerging 3D cell culture system, organoid technology has demonstrated substantial potential in basic research and ...

Fisher's team researched and used 3-D Bioprinting to create a "nipple-areola complex" or NAC. "We have a lot of flexibility ...

Some of us still remember when fax machines were the height of technology, so it’s safe to say this one blew our minds a ...